Header Logo

Connection

Xiaoduo Fan to Schizophrenia

Back to Details
This is a "connection" page, showing publications Xiaoduo Fan has written about Schizophrenia.
Xiaoduo Fan
Connection Strength
8.508
Schizophrenia
  1. Fattahi C, Hamada K, Chiang M, Kosuru S, Polavarapu M, Sitthichai R, Fan X. A narrative review of mindfulness-based therapy for schizophrenia, co-occurring substance use and comorbid cardiometabolic problems. Psychiatry Res. 2021 02; 296:113707.
    View in: PubMed
    Score: 0.588
  2. Oh SJ, Fan X. Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia. Schizophr Res. 2020 08; 222:23-30.
    View in: PubMed
    Score: 0.564
  3. Li H, Ou Y, Liu F, Chen J, Zhao J, Guo W, Fan X. Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis. Schizophr Res. 2020 01; 215:337-343.
    View in: PubMed
    Score: 0.537
  4. Oh SJ, Fan X. The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy. CNS Drugs. 2019 06; 33(6):539-547.
    View in: PubMed
    Score: 0.526
  5. Chiang M, Reid-Varley WB, Fan X. Creative art therapy for mental illness. Psychiatry Res. 2019 05; 275:129-136.
    View in: PubMed
    Score: 0.519
  6. Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957.
    View in: PubMed
    Score: 0.516
  7. Robertson I, Cheung A, Fan X. Insomnia in patients with schizophrenia: current understanding and treatment options. Prog Neuropsychopharmacol Biol Psychiatry. 2019 06 08; 92:235-242.
    View in: PubMed
    Score: 0.514
  8. Liu F, Zhang B, Xie L, Ruan Y, Xu X, Zeng Y, Messina L, Zhao J, Fan X. Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia. Schizophr Res. 2018 09; 199:390-394.
    View in: PubMed
    Score: 0.483
  9. Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017 08 01; 78:1-11.
    View in: PubMed
    Score: 0.456
  10. Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016 Feb; 19(1):6-9.
    View in: PubMed
    Score: 0.416
  11. Rajan S, Zalpuri I, Harrington A, Cimpeanu C, Song X, Fan X. Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. Int Clin Psychopharmacol. 2016 Jan; 31(1):51-6.
    View in: PubMed
    Score: 0.415
  12. Song X, Quan M, Lv L, Li X, Pang L, Kennedy D, Hodge S, Harrington A, Ziedonis D, Fan X. Decreased cortical thickness in drug na?ve first episode schizophrenia: in relation to serum levels of BDNF. J Psychiatr Res. 2015 Jan; 60:22-8.
    View in: PubMed
    Score: 0.380
  13. Sheng J, Li C, Wang J, Chiang C, Harrington A, Yi Z, Liu D, Fan X. Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia. Psychiatry Res. 2014 Dec 15; 220(1-2):71-5.
    View in: PubMed
    Score: 0.375
  14. Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30.
    View in: PubMed
    Score: 0.343
  15. Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26.
    View in: PubMed
    Score: 0.330
  16. Yuan X, Li X, Kang Y, Pang L, Hei G, Zhang X, Wang S, Zhao X, Zhang S, Tao Q, Zhang L, Zhu Q, Lv L, Fan X, Hu S, Song X. Gut mycobiota dysbiosis in drug-na?ve, first-episode schizophrenia. Schizophr Res. 2022 Dec; 250:76-86.
    View in: PubMed
    Score: 0.167
  17. Li X, Yuan X, Pang L, Zhang S, Li Y, Huang X, Fan X, Song X. The effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-na?ve, first episode schizophrenia patients. Psychiatry Res. 2022 07; 313:114582.
    View in: PubMed
    Score: 0.161
  18. Li M, Qiu Y, Zhang J, Zhang Y, Liu Y, Zhao Y, Jia Q, Fan X, Li J. Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2022 Jun; 272(4):633-642.
    View in: PubMed
    Score: 0.158
  19. Chiang M, Lombardi D, Du J, Makrum U, Sitthichai R, Harrington A, Shukair N, Zhao M, Fan X. Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options. Hum Psychopharmacol. 2019 09; 34(5):e2710.
    View in: PubMed
    Score: 0.134
  20. Li H, Guo W, Liu F, Chen J, Su Q, Zhang Z, Fan X, Zhao J. Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples. EBioMedicine. 2019 Aug; 46:248-255.
    View in: PubMed
    Score: 0.133
  21. Zhu F, Liu F, Guo W, Chen J, Su Q, Zhang Z, Li H, Fan X, Zhao J. Disrupted asymmetry of inter- and intra-hemispheric functional connectivity in patients with drug-naive, first-episode schizophrenia and their unaffected siblings. EBioMedicine. 2018 Oct; 36:429-435.
    View in: PubMed
    Score: 0.125
  22. Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, Hei G, Lv L, Huang XF, Fan X, Song X. Changes in metabolism and microbiota after 24-week risperidone treatment in drug na?ve, normal weight patients with first episode schizophrenia. Schizophr Res. 2018 11; 201:299-306.
    View in: PubMed
    Score: 0.123
  23. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403.
    View in: PubMed
    Score: 0.095
  24. Song X, Fan X, Li X, Kennedy D, Pang L, Quan M, Chen X, Gao J, Zhang W, Zhang J, Lv L. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug na?ve, first episode schizophrenia. Schizophr Res. 2014 Oct; 159(1):51-5.
    View in: PubMed
    Score: 0.094
  25. Song X, Li X, Gao J, Zhao J, Li Y, Fan X, Lv L. APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia. PLoS One. 2014; 9(4):e93902.
    View in: PubMed
    Score: 0.092
  26. Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Fan X, Lv L. Activation of Th17 cells in drug na?ve, first episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 03; 51:78-82.
    View in: PubMed
    Score: 0.091
  27. Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L. Elevated levels of adiponectin and other cytokines in drug na?ve, first episode schizophrenia patients with normal weight. Schizophr Res. 2013 Oct; 150(1):269-73.
    View in: PubMed
    Score: 0.088
  28. Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.